RU2649141C2 - 3,4-dimethyl-6-(3-pyridyl)-n-phenyl-2-oxo-1,2,3,6-tetrahydropyrimidine-5-carboxamide with antifungal activity against the candida albicans strain - Google Patents
3,4-dimethyl-6-(3-pyridyl)-n-phenyl-2-oxo-1,2,3,6-tetrahydropyrimidine-5-carboxamide with antifungal activity against the candida albicans strain Download PDFInfo
- Publication number
- RU2649141C2 RU2649141C2 RU2015114858A RU2015114858A RU2649141C2 RU 2649141 C2 RU2649141 C2 RU 2649141C2 RU 2015114858 A RU2015114858 A RU 2015114858A RU 2015114858 A RU2015114858 A RU 2015114858A RU 2649141 C2 RU2649141 C2 RU 2649141C2
- Authority
- RU
- Russia
- Prior art keywords
- compound
- candida albicans
- tetrahydropyrimidine
- oxo
- dimethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
Description
Изобретение относится к области органической химии, производным пиримидина, а именно новому биологически активному 3,4-диметил-6-(3-пиридил)-N-фенил-2-оксо-1,2,3,6-тетрагидропиримидин-5-карбоксамиду (1) формулы:The invention relates to the field of organic chemistry, derivatives of pyrimidine, namely the new biologically active 3,4-dimethyl-6- (3-pyridyl) -N-phenyl-2-oxo-1,2,3,6-tetrahydropyrimidine-5-carboxamide (1) formulas:
обладающему противогрибковым действием в отношении штамма Candida albicans, что позволяет предположить его использование в медицинской практике в качестве противогрибкового средства.possessing an antifungal effect against the strain of Candida albicans, which suggests its use in medical practice as an antifungal agent.
Ближайшим структурным аналогом к заявляемому соединению является соединение формулы 2, проявляющее антигипертензивное свойство [Wan, Jie-Ping. Synthesis of Dihydropyrimidinones and Thiones by Multicomponent Reactions: Strategies Beyond the Classical Biginelli Reaction / Jie-Ping Wan, Yunyun Liu // Synthesis. - 2012. - №23. - P. 3943-3953].The closest structural analogue to the claimed compound is a compound of formula 2, exhibiting antihypertensive property [Wan, Jie-Ping. Synthesis of Dihydropyrimidinones and Thiones by Multicomponent Reactions: Strategies Beyond the Classical Biginelli Reaction / Jie-Ping Wan, Yunyun Liu // Synthesis. - 2012. - No. 23. - P. 3943-3953].
Целью предлагаемого изобретения является поиск среди производных пиримидина соединений, обладающих противогрибковой активностью в отношении штамма Candida albicans.The aim of the invention is to search among derivatives of pyrimidine compounds having antifungal activity against a strain of Candida albicans.
Поставленная цель достигается получением 3,4-диметил-6-(3-пиридил)-N-фенил-2-оксо-1,2,3,6-тетрагидропиримидин-5-карбоксамида (1), который синтезируют трехкомпонентной реакцией ацетоацетанилида, 3-пиридинкарбоксальдегида, N-метилмочевины [Синтез диарилзамещенных 3,4-диметил-2-оксо-1,2,3,6-тетрагидропиримидин-5-карбоксамидов / В.Л. Гейн, А.Ю. Федотов, Т.М. Замараева [и др.] // Журн. общей химии. - 2013. - Т. 83, №4. - С. 701-702].This goal is achieved by obtaining 3,4-dimethyl-6- (3-pyridyl) -N-phenyl-2-oxo-1,2,3,6-tetrahydropyrimidine-5-carboxamide (1), which is synthesized by a three-way reaction of acetoacetanilide, 3 -pyridinecarboxaldehyde, N-methylurea [Synthesis of diaryl-substituted 3,4-dimethyl-2-oxo-1,2,3,6-tetrahydropyrimidine-5-carboxamides / V.L. Gain, A.Yu. Fedotov, T.M. Zamaraeva [et al.] // Zh. general chemistry. - 2013. - T. 83, No. 4. - S. 701-702].
Методика получения 3,4-диметил-6-(3-пиридил)-N-фенил-2-оксо-1,2,3,6-тетрагидропиримидин-5-карбоксамидаThe method of obtaining 3,4-dimethyl-6- (3-pyridyl) -N-phenyl-2-oxo-1,2,3,6-tetrahydropyrimidine-5-carboxamide
Смесь 1.77 г (0.01 моль) ацетоацетанилида, 0.94 мл (0.01 моль) 3-пиридинкарбоксальдегида и 0.74 (0.01 моль) N-метилмочевины выдерживали при температуре 120-150°C до прекращения газовыделения и затвердения реакционной смеси, после охлаждения остаток обрабатывали этанолом, отфильтровывали и перекристаллизовывали из этилового спирта. Выход составляет 2.77 г (86%).A mixture of 1.77 g (0.01 mol) of acetoacetanilide, 0.94 ml (0.01 mol) of 3-pyridinecarboxaldehyde and 0.74 (0.01 mol) of N-methylurea was kept at a temperature of 120-150 ° C until gas evolution ceased and the reaction mixture solidified, after cooling, the residue was treated with ethanol and filtered and recrystallized from ethyl alcohol. The yield is 2.77 g (86%).
Заявляемое соединение представляет собой бесцветное кристаллическое вещество, растворимое в ДМФА, уксусной кислоте, при нагревании - в этиловом спирте, устойчивое при хранении. Tпл 243-245°C. Вычислено, % С 67.07; Н 5.63; N 17.38. C18H18N4O2. Найдено, % С 67.19, 66.96; Н 5.71, 5.54; N 17.48, 17.27.The inventive compound is a colorless crystalline substance soluble in DMF, acetic acid, when heated in ethanol, stable during storage. T mp 243-245 ° C. Calculated,% C 67.07; H 5.63; N, 17.38. C 18 H 18 N 4 O 2 . Found,% C 67.19, 66.96; H 5.71, 5.54; N 17.48, 17.27.
Спектр ЯМР 1Н соединения 1 снят при рабочей частоте 300 Мгц, внутренний эталон ТМС. Спектр ЯМР 1Н, δ, м.д. J, Гц: 2.17 с (3Н, 4-СН3), 3.06 с (3Н, 3-СН3), 5.26 д (1Н, 6-СН, J=1.8 Гц), 6.91-7.56 м (9Н, С6Н5, C5H4N), 7.66 д (1Н, 1-NH, J=1.8 Гц), 9.68 с (1Н, NH).The 1 H NMR spectrum of compound 1 was recorded at an operating frequency of 300 MHz, and the internal TMS standard. 1 H NMR spectrum, δ, ppm J, Hz: 2.17 s (3H, 4-CH 3 ), 3.06 s (3H, 3-CH 3 ), 5.26 d (1H, 6-CH, J = 1.8 Hz), 6.91-7.56 m (9H, C 6 H 5 , C 5 H 4 N), 7.66 d (1H, 1-NH, J = 1.8 Hz), 9.68 s (1H, NH).
ИК-спектр снят для соединения 1 в вазелиновом масле. В ИК-спектре соединения 1 наблюдаются полосы, обусловленные валентными колебаниями амидной группы (1696 см-1), связи NH (3136 см-1), а также полоса С=С в области 1608 см-1.The IR spectrum was taken for compound 1 in liquid paraffin. In the IR spectrum of compound 1, bands are observed due to stretching vibrations of the amide group (1696 cm -1 ), NH bonds (3136 cm -1 ), and the C = C band in the region of 1608 cm -1 .
Соединение 1 исследовали на наличие противогрибковой активности. Противогрибковую активность определяли методом серийных разведений в жидкой питательной среде Сабуро. Для испытуемого соединения была определена минимальная подавляющая концентрация (МПК, мкг/мл) в отношении фармакопейного штамма Candida albicans.Compound 1 was tested for antifungal activity. Antifungal activity was determined by the method of serial dilutions in a liquid nutrient medium Saburo. For the test compound, the minimum inhibitory concentration (MIC, μg / ml) was determined for the pharmacopeia strain of Candida albicans.
В качестве эталона сравнения использовали флуконазол. Результаты исследования приведены в таблице 1.Fluconazole was used as a reference standard. The results of the study are shown in table 1.
Острую токсичность определяли при внутрибрюшинном введении нелинейным белым мышам массой 20-25 г. Результаты обрабатывали по Прозоровскому с вычислением средней смертельной дозы (ЛД50) [Прозоровский В.В., Прозоровская М.П., Демченко В.М. // Фармакология и токсикология. - 1978. - Т. 41. - №4. - С. 497-502]. Острая токсичность (ЛД50) заявляемого соединения составила 5640 (>5100) мг/кг.Acute toxicity was determined by intraperitoneal administration to nonlinear white mice weighing 20-25 g. The results were processed according to Prozorovsky with the calculation of the average lethal dose (LD 50 ) [Prozorovsky VV, Prozorovskaya MP, Demchenko VM // Pharmacology and toxicology. - 1978. - T. 41. - No. 4. - S. 497-502]. Acute toxicity (LD 50 ) of the claimed compounds was 5640 (> 5100) mg / kg
Таким образом, заявляемое соединение 1 -3,4-диметил-6-(3-пиридил)-N-фенил-2-оксо-1,2,3,6-тетрагидропиримидин-5-карбоксамид проявляет противогрибковое действие в отношении штамма Candida albicans, равное активности флуконазола, но менее токсичное в 3 раза.Thus, the claimed compound 1 -3,4-dimethyl-6- (3-pyridyl) -N-phenyl-2-oxo-1,2,3,6-tetrahydropyrimidine-5-carboxamide exhibits antifungal activity against a strain of Candida albicans equal to the activity of fluconazole, but less toxic 3 times.
ЛитератураLiterature
1. Wan, Jie-Ping. Synthesis of Dihydropyrimidinones and Thiones by Multicomponent Reactions: Strategies Beyond the Classical Biginelli Reaction / Jie-Ping Wan, Yunyun Liu // Synthesis. - 2012. - №23. - P. 3943-3953.1. Wan, Jie-Ping. Synthesis of Dihydropyrimidinones and Thiones by Multicomponent Reactions: Strategies Beyond the Classical Biginelli Reaction / Jie-Ping Wan, Yunyun Liu // Synthesis. - 2012. - No. 23. - P. 3943-3953.
2. Синтез диарилзамещенных 3,4-диметил-2-оксо-1,2,3,6-тетрагидропиримидин-5-карбоксамидов / В.Л. Гейн, А.Ю. Федотов, Т.М. Замараева [и др.] // Журн. общей химии. - 2013. - Т. 83, №4. - С. 701-702.2. Synthesis of diaryl substituted 3,4-dimethyl-2-oxo-1,2,3,6-tetrahydropyrimidine-5-carboxamides / V.L. Gain, A.Yu. Fedotov, T.M. Zamaraeva [et al.] // Zh. general chemistry. - 2013. - T. 83, No. 4. - S. 701-702.
3. Прозоровский В.В., Прозоровская М.П., Демченко В.М. // Фармакология и токсикология. - 1978. - Т. 41. - №4. - С. 497-502.3. Prozorovsky V.V., Prozorovskaya M.P., Demchenko V.M. // Pharmacology and toxicology. - 1978. - T. 41. - No. 4. - S. 497-502.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2015114858A RU2649141C2 (en) | 2015-04-20 | 2015-04-20 | 3,4-dimethyl-6-(3-pyridyl)-n-phenyl-2-oxo-1,2,3,6-tetrahydropyrimidine-5-carboxamide with antifungal activity against the candida albicans strain |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2015114858A RU2649141C2 (en) | 2015-04-20 | 2015-04-20 | 3,4-dimethyl-6-(3-pyridyl)-n-phenyl-2-oxo-1,2,3,6-tetrahydropyrimidine-5-carboxamide with antifungal activity against the candida albicans strain |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2015114858A RU2015114858A (en) | 2016-11-10 |
RU2649141C2 true RU2649141C2 (en) | 2018-03-30 |
Family
ID=57267627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2015114858A RU2649141C2 (en) | 2015-04-20 | 2015-04-20 | 3,4-dimethyl-6-(3-pyridyl)-n-phenyl-2-oxo-1,2,3,6-tetrahydropyrimidine-5-carboxamide with antifungal activity against the candida albicans strain |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2649141C2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2785688C1 (en) * | 2022-07-06 | 2022-12-12 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермская государственная фармацевтическая академия" Министерства здравоохранения Российской Федерации | Use of 3,4-dimethyl-6-(3-nitrophenyl)-2-oxo-n-phenyl-1,2,3,6-tetrahydropyrimidine-5-carboxamide as agent with analgesic activity |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2004135554A (en) * | 2002-05-09 | 2006-01-20 | Цитокинетикс, Инк. (Us) | Pyrimidinones, compositions based on them and methods for their use |
RU2473549C2 (en) * | 2008-07-31 | 2013-01-27 | Дженентек, Инк. | Pyrimidine compounds, compositions and methods of use |
WO2013093484A1 (en) * | 2011-12-21 | 2013-06-27 | Ono Pharmaceutical Co., Ltd. | Pyridinone and pyrimidinone derivatives as factor xia inhibitors |
-
2015
- 2015-04-20 RU RU2015114858A patent/RU2649141C2/en not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2004135554A (en) * | 2002-05-09 | 2006-01-20 | Цитокинетикс, Инк. (Us) | Pyrimidinones, compositions based on them and methods for their use |
RU2473549C2 (en) * | 2008-07-31 | 2013-01-27 | Дженентек, Инк. | Pyrimidine compounds, compositions and methods of use |
WO2013093484A1 (en) * | 2011-12-21 | 2013-06-27 | Ono Pharmaceutical Co., Ltd. | Pyridinone and pyrimidinone derivatives as factor xia inhibitors |
Non-Patent Citations (2)
Title |
---|
RU 2473549 C2 ( ДЖЕНЕНТЕК, ИНК.), 27.01.2013. RU 2004135554 А (ЦИТОКИНЕТИКС, ИНК.), 20.01.2006. WO 2013093484 A1 (ONO PHARMACEUTICAL CO., LTD), 27.06.2013. * |
ЖУРНАЛ ОБЩЕЙ ХИМИИ, "Наука", Санкт -Петербург, 2013, т. 83 (145), с. 701-702. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2785688C1 (en) * | 2022-07-06 | 2022-12-12 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермская государственная фармацевтическая академия" Министерства здравоохранения Российской Федерации | Use of 3,4-dimethyl-6-(3-nitrophenyl)-2-oxo-n-phenyl-1,2,3,6-tetrahydropyrimidine-5-carboxamide as agent with analgesic activity |
Also Published As
Publication number | Publication date |
---|---|
RU2015114858A (en) | 2016-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dogan et al. | Synthesis of new 2, 5-disubstituted-1, 3, 4-thiadiazoles and preliminary evaluation of anticonvulsant and antimicrobial activities | |
JPWO2014017515A1 (en) | Crystalline polymorph of 4- [5- (pyridin-4-yl) -1H-1,2,4-triazol-3-yl] pyridine-2-carbonitrile and process for producing the same | |
Burch et al. | Nitrofuryl Heterocycles. III. 1 3-Alkyl-5-(5-nitro-2-furyl)-1, 2, 4-triazoles and Intermediates | |
RU2389724C1 (en) | 4-(4-methylphenyl)-4-oxo-2-[3-(ethoxycarbonyl-4,5-r2,r1-thiophen-2-ylamino]but-2-enoic acid, having anti-inflammatory and analgesic activity | |
RU2649141C2 (en) | 3,4-dimethyl-6-(3-pyridyl)-n-phenyl-2-oxo-1,2,3,6-tetrahydropyrimidine-5-carboxamide with antifungal activity against the candida albicans strain | |
Gein et al. | Synthesis and Antimicrobial Activity of 5-Aryl-4-Acyl-3-Hydroxy-1-[2-(2-Hydroxyethoxy)-Ethyl]-3-Pyrrolin-2-Ones | |
RU2653511C2 (en) | 4-methyl-n-2,4-dimethylphenyl-6-(3-fluorophenyl)-2-thyoxo-1,2,3,6-tetragydropyrimidine-5-carboxamide that has analgetic action | |
RU2503671C1 (en) | (Z)-2-[(3-CARBAMOYL-4,5,6,7-TETRAHYDROBENZO[b]THIEN-2-YL)AMINO]-4-(4-R-PHENYL)-4-OXOBUT-2-ENOIC ACIDS, HAVING ANALGESIC ACTIVITY | |
Arafa et al. | Prospective Study Directed to the Synthesis of Symmetrical Linked Bis-rhodanine Derivatives with Their Antimicrobial Activity | |
RU2364592C1 (en) | N-[2-(5-ethyl-1,3,4-thiadiazolyl)]amide of 2-(2-hydroxyphenyl)-2-oxoethane acid, possessing anti-inflammatory and analgesic activity | |
Armisheva et al. | Reactions of 5-aryl-4-acyl-1-(4-hydroxyphenyl)-3-hydroxy-3-pyrrolin-2-ones with arylamines | |
Gein et al. | Synthesis and antibacterial activity of 4-aryl-2-hydroxy-4-oxo-2-butenoic (aroylpyruvic) acids N-(4-guanidylsulfonylphenyl) amides | |
Gein et al. | Synthesis and antimicrobial activity of 5-aryl-4-acyl (heteroyl)-3-hydroxy-1-(3-ethoxypropyl)-3-pyrrolin-2-ones | |
ES2439322T3 (en) | Amino alcohol derivatives and their therapeutic activities | |
CN102229578B (en) | Preparation method of 2-arylamino-1,3,4-oxadiazole compound | |
RU2763728C1 (en) | Application of 3-(2-(4-nitrophenyl)-2-oxoethylidene)morpholin-2-one as antimicrobial agent | |
Gein et al. | Synthesis and antibacterial activity of 5-aryl-4-acyl-3-hydroxy-1-(2-hydroxyethyl)-3-pyrrolin-2-ones | |
Velikorodov et al. | Synthesis and antimycobacterial activity of carbamate derivatives of 1, 2-oxazine | |
RU2738405C1 (en) | Amide (e)-2-amino-4-oxo-5-(2-oxo-2-phenylethylidene)-1-(3-ethoxycarbonyl)-4,5,6-7-tetrahydrobenzo[b]thiophen-2-yl)4,5-dihydro-1h-pyrrole-3-carboxylic acid, having antimicrobial activity | |
RU2809002C1 (en) | Use of 1-acetyl-2-(2-oxobutyl)-6-chlorindolin-3-one as antifungal agent against yeast fungi | |
Gautam et al. | Synthesis, antimicrobial, insecticidal and anthelmintic activity studies of some new alkyl/aryl 6-(4-(4-(4-methyl-1H-1, 2, 3-triazol-1-yl) phenyl amino) phenyl)-N 2, N 4-bis (4-methoxyphenyl)-1, 3, 5-triazin-2, 4-diamine carbamic acid ester derivatives | |
Sajjad et al. | Synthesis, Characterization, and Antimicrobial Activity of Some New Tetrazole Derivatives from Hydrazones | |
RU2763735C1 (en) | Application of antimicrobial agent for golden staphylococcus with multiple drug resistance based on 2-((4-r1-5-r2-3-(ethoxicarbonyl)thiophene-2-yl)amino-4-r3-oxo-enoic acids | |
RU2808994C1 (en) | Use of 1-acetyl-2-(2-oxopropyl)-5-chlorindolin-3-one as antifungal agent against yeasts | |
RU2785779C1 (en) | Use of ethyl-4-(4-hydroxy-2-oxo-4-(thiophene-2-yl)but-3-enthioamido)benzoate for treatment of diseases caused by golden staphylococcus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20180421 |